Workshop 1 : Response Biomarker and Management of irAEs in Immune Checkpoint Inhibitor Therapy
Correlation of Inflammatory Blood Markers with Clinical Response in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Treated by Nivolumab